Opposing Actions of Adrenocorticotropic Hormone and Glucocorticoids on UCP1-Mediated Respiration in Brown Adipocytes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Expression in 3T3-L1 Adipocytes (Obesity/Nuclear Receptor/Peroxisome Proliferator-Activated Receptor Y) CALEB B
Proc. Natl. Acad. Sci. USA Vol. 93, pp. 5793-5796, June 1996 Cell Biology Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes (obesity/nuclear receptor/peroxisome proliferator-activated receptor y) CALEB B. KALLEN AND MITCHELL A. LAZAR Division of Endocrinology, Diabetes, and Metabolism, Departments of Medicine and Genetics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 Communicated by M. Daniel Lane, Johns Hopkins University School of Medicine, Baltimore, MD, February 20, 1996 (receivedfor review January 11, 1996) ABSTRACT Lack of leptin (ob) protein causes obesity in We hypothesized that thiazolidinediones, which regulate the mice. The leptin gene product is important for normal regu- expression of adipocyte-specific genes via PPARy (14), might lation of appetite and metabolic rate and is produced exclu- also play a role in the regulation of leptin gene expression. We sively by adipocytes. Leptin mRNA was induced during the found that several thiazolidinediones dramatically repressed adipose conversion of 3T3-L1 cells, which are useful for leptin gene expression in differentiated 3T3-L1 adipocytes. studying adipocyte differentiation and function under con- The ED50 for inhibition of leptin expression by the thiazo- trolled conditions. We studied leptin regulation by antidia- lidinedione BRL49653 was similar to its ED50 for inducing betic thiazolidinedione compounds, which are ligands for the adipocyte differentiation and to its reported Kd for binding to adipocyte-specific nuclear receptor peroxisome proliferator- PPARy. Thus, antidiabetic thiazolidinediones down-regulate activated receptor y (PPARy) that regulates the transcription leptin expression in 3T3-L1 adipocytes by a mechanism that of other adipocyte-specific genes. Remarkably, leptin gene may involve PPARy. -
Cognition and Steroidogenesis in the Rhesus Macaque
Cognition and Steroidogenesis in the Rhesus Macaque Krystina G Sorwell A DISSERTATION Presented to the Department of Behavioral Neuroscience and the Oregon Health & Science University School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2013 School of Medicine Oregon Health & Science University CERTIFICATE OF APPROVAL This is to certify that the PhD dissertation of Krystina Gerette Sorwell has been approved Henryk Urbanski Mentor/Advisor Steven Kohama Member Kathleen Grant Member Cynthia Bethea Member Deb Finn Member 1 For Lily 2 TABLE OF CONTENTS Acknowledgments ......................................................................................................................................................... 4 List of Figures and Tables ............................................................................................................................................. 7 List of Abbreviations ................................................................................................................................................... 10 Abstract........................................................................................................................................................................ 13 Introduction ................................................................................................................................................................. 15 Part A: Central steroidogenesis and cognition ............................................................................................................ -
ACTH Enhances Lipid Accumulation in Bone-Marrow Derived Mesenchymal Stem Cells Undergoing Adipogenesis" (2015)
Molloy College DigitalCommons@Molloy Faculty Works: Biology, Chemistry, and Biology, Chemistry, and Environmental Science Environmental Studies 2015 ACTH Enhances Lipid Accumulation in Bone- marrow derived Mesenchymal stem cells undergoing adipogenesis Jodi F. Evans Ph.D. Molloy College, [email protected] Thomas Rhodes Michelle Pazienza Follow this and additional works at: https://digitalcommons.molloy.edu/bces_fac Part of the Biology Commons, and the Chemistry Commons DigitalCommons@Molloy Feedback Recommended Citation Evans, Jodi F. Ph.D.; Rhodes, Thomas; and Pazienza, Michelle, "ACTH Enhances Lipid Accumulation in Bone-marrow derived Mesenchymal stem cells undergoing adipogenesis" (2015). Faculty Works: Biology, Chemistry, and Environmental Studies. 11. https://digitalcommons.molloy.edu/bces_fac/11 This Peer-Reviewed Article is brought to you for free and open access by the Biology, Chemistry, and Environmental Science at DigitalCommons@Molloy. It has been accepted for inclusion in Faculty Works: Biology, Chemistry, and Environmental Studies by an authorized administrator of DigitalCommons@Molloy. For more information, please contact [email protected],[email protected]. Journal of Student Research (2015) Volume 4, Issue 1: pp. 69-73 Research Article ACTH Enhances Lipid Accumulation in Bone-marrow derived Mesenchymal stem cells undergoing adipogenesis Thomas Rhodesa, Michelle Pazienzaa and Jodi F. Evansa ACTH is a major hormone of the stress axis or hypothalamic-pituitary-adrenal (HPA) axis. It is derived from pro- opiomelanocortin (POMC) the precursor to the melanocortin family of peptides. POMC produces the biologically active melanocortin peptides via a series of enzymatic steps in a tissue-specific manner, yielding the melanocyte-stimulating hormones (MSHs), corticotrophin (ACTH) and β-endorphin. The melanocortin system plays an imperative role in energy expenditure, insulin release and insulin sensitivity. -
The Mechanism of White and Brown Adipocyte Differentiation
Review Obesity and Metabolic Syndrome Diabetes Metab J 2013;37:85-90 http://dx.doi.org/10.4093/dmj.2013.37.2.85 pISSN 2233-6079 · eISSN 2233-6087 DIABETES & METABOLISM JOURNAL The Mechanism of White and Brown Adipocyte Differentiation Hironori Nakagami Division of Vascular Medicine and Epigenetics, Osaka University United Graduate School of Child Development, Osaka, Japan Obesity gives vent to many diseases such as type 2 diabetes, hypertension, and hyperlipidemia, being considered as the main causes of mortality and morbidity worldwide. The pathogenesis and pathophysiology of metabolic syndrome can well be under- stood by studying the molecular mechanisms that control the development and function of adipose tissue. In human body, exist two types of adipose tissue, the white and the brown one, which are reported to play various roles in energy homeostasis. The major and most efficient storage of energy occurs in the form of triglycerides in white adipose tissue while brown adipose tissue actively participates in both basal and inducible energy consumption in the form of thermogenesis. Recent years have observed a rapid and greater interest towards developmental plasticity and therapeutic potential of stromal cells those isolated from adipose tissue. The adipocyte differentiation involves a couple of regulators in the white or brown adipogenesis. Peroxisome prolifera- tors-activated receptor-γ actively participates in regulating carbohydrate and lipid metabolism, and also acts as main regulator of both white and brown adipogenesis. This review based on our recent research, seeks to highlight the adipocyte differentiation. Keywords: Adipogenesis; Adipose tissue, brown; Genes, homeobox; miR-196a; Obesity INTRODUCTION cells (MSCs) which differentiate into multiple lineages such as adipocytes in vitro, providing a unique platform to study mo- Obesity has emerged as one of the deadliest life threat of the lecular machineries of adipocyte differentiation. -
Contribution of Adipogenesis to Healthy Adipose Tissue Expansion in Obesity
Contribution of adipogenesis to healthy adipose tissue expansion in obesity Lavanya Vishvanath, Rana K. Gupta J Clin Invest. 2019;129(10):4022-4031. https://doi.org/10.1172/JCI129191. Review Series The manner in which white adipose tissue (WAT) expands and remodels directly impacts the risk of developing metabolic syndrome in obesity. Preferential accumulation of visceral WAT is associated with increased risk for insulin resistance, whereas subcutaneous WAT expansion is protective. Moreover, pathologic WAT remodeling, typically characterized by adipocyte hypertrophy, chronic inflammation, and fibrosis, is associated with insulin resistance. Healthy WAT expansion, observed in the “metabolically healthy” obese, is generally associated with the presence of smaller and more numerous adipocytes, along with lower degrees of inflammation and fibrosis. Here, we highlight recent human and rodent studies that support the notion that the ability to recruit new fat cells through adipogenesis is a critical determinant of healthy adipose tissue distribution and remodeling in obesity. Furthermore, we discuss recent advances in our understanding of the identity of tissue-resident progenitor populations in WAT made possible through single-cell RNA sequencing analysis. A better understanding of adipose stem cell biology and adipogenesis may lead to novel strategies to uncouple obesity from metabolic disease. Find the latest version: https://jci.me/129191/pdf REVIEW SERIES: MECHANISMS UNDERLYING THE METABOLIC SYNDROME The Journal of Clinical Investigation Series Editor: Philipp E. Scherer Contribution of adipogenesis to healthy adipose tissue expansion in obesity Lavanya Vishvanath and Rana K. Gupta Touchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. The manner in which white adipose tissue (WAT) expands and remodels directly impacts the risk of developing metabolic syndrome in obesity. -
G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes
Int. J. Mol. Sci. 2014, 15, 1112-1142; doi:10.3390/ijms15011112 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review G Protein-Coupled Receptors: What a Difference a ‘Partner’ Makes Benoît T. Roux 1 and Graeme S. Cottrell 2,* 1 Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK; E-Mail: [email protected] 2 Reading School of Pharmacy, University of Reading, Reading RG6 6UB, UK * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +44-118-378-7027; Fax: +44-118-378-4703. Received: 4 December 2013; in revised form: 20 December 2013 / Accepted: 8 January 2014 / Published: 16 January 2014 Abstract: G protein-coupled receptors (GPCRs) are important cell signaling mediators, involved in essential physiological processes. GPCRs respond to a wide variety of ligands from light to large macromolecules, including hormones and small peptides. Unfortunately, mutations and dysregulation of GPCRs that induce a loss of function or alter expression can lead to disorders that are sometimes lethal. Therefore, the expression, trafficking, signaling and desensitization of GPCRs must be tightly regulated by different cellular systems to prevent disease. Although there is substantial knowledge regarding the mechanisms that regulate the desensitization and down-regulation of GPCRs, less is known about the mechanisms that regulate the trafficking and cell-surface expression of newly synthesized GPCRs. More recently, there is accumulating evidence that suggests certain GPCRs are able to interact with specific proteins that can completely change their fate and function. These interactions add on another level of regulation and flexibility between different tissue/cell-types. -
Effects of Chronic Psychosocial Stress on HPA Axis Functionality in Male C57BL/6 Mice and the Impact of Trait Anxiety on the Individual Stress Vulnerability
Effects of chronic psychosocial stress on HPA axis functionality in male C57BL/6 mice and the impact of trait anxiety on the individual stress vulnerability DISSERTATION ZUR ERLANGUNG DES DOKTORGRADES DER NATURWISSENSCHAFTEN (DR. RER. NAT.) DER FAKULTÄT FÜR BIOLOGIE UND VORKLINISCHE MEDIZIN DER UNIVERSITÄT REGENSBURG vorgelegt von Andrea Monika Füchsl aus Straubing im Jahr 2013 Das Promotionsgesuch wurde eingereicht am: 04.10.2013 Die Arbeit wurde angeleitet von: Prof. Dr. rer. nat. Inga D. Neumann Unterschrift: DISSERTATION Durchgeführt am Institut für Zoologie der Universität Regensburg TABLE OF CONTENTS I Table of Contents Chapter 1 – Introduction 1 Stress ...................................................................................................... 1 1.1 The Stress System ..................................................................................... 1 1.1.2 Sympathetic nervous system (SNS) ..................................................... 2 1.2.2 Hypothalamic-Pituitary-Adrenal (HPA) axis .......................................... 4 1.2 Acute vs. chronic/repeated stress ............................................................. 13 1.3 Psychosocial stress .................................................................................. 18 2 GC Signalling ....................................................................................... 20 2.1 Corticosteroid availability .......................................................................... 20 2.2 Corticosteroid receptor types in the brain ................................................. -
Adipogenesis at a Glance
Cell Science at a Glance 2681 Adipogenesis at a Stephens, 2010). At the same time attention has This Cell Science at a Glance article reviews also shifted to many other aspects of adipocyte the transition of precursor stem cells into mature glance development, including efforts to identify, lipid-laden adipocytes, and the numerous isolate and manipulate relevant precursor stem molecules, pathways and signals required to Christopher E. Lowe, Stephen cells. Recent studies have revealed new accomplish this. O’Rahilly and Justin J. Rochford* intracellular pathways, processes and secreted University of Cambridge Metabolic Research factors that can influence the decision of these Adipocyte stem cells Laboratories, Institute of Metabolic Science, cells to become adipocytes. Pluripotent mesenchymal stem cells (MSCs) Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK Understanding the intricacies of adipogenesis can be isolated from several tissues, including *Author for correspondence ([email protected]) is of major relevance to human disease, as adipose tissue. Adipose-derived MSCs have the Journal of Cell Science 124, 2681-2686 adipocyte dysfunction makes an important capacity to differentiate into a variety of cell © 2011. Published by The Company of Biologists Ltd doi:10.1242/jcs.079699 contribution to metabolic disease in obesity types, including adipocytes, osteoblasts, (Unger et al., 2010). Thus, improving adipocyte chondrocytes and myocytes. Until recently, The formation of adipocytes from precursor function and the complementation or stem cells in the adipose tissue stromal vascular stem cells involves a complex and highly replacement of poorly functioning adipocytes fraction (SVF) have been typically isolated in orchestrated programme of gene expression. could be beneficial in common metabolic pools that contain a mixture of cell types, and the Our understanding of the basic network of disease. -
Expression of Μ-Opiate Receptor in Human Epidermis and Keratinocytes
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Expression of µ-Opiate Receptor in Human Epidermis and Keratinocytes Paul L. Bigliardi, Mei Bigliardi-Qi, Stanislaus Buechner, and Theo Rufli Department of Dermatology, Kantonsspital Basel, Basel, Switzerland There is increasing evidence that neurotransmitters play which was more distinct in the suprabasal layers. a crucial role in skin physiology and pathology. The Immunohistochemistry using the µ-opiate receptor- expression and production of proopiomelanocortin mole- specific antibody indicates that epidermis expresses pro- cules such as β-endorphin in human epidermis suggest tein as well, and that the protein level is more elevated that an opiate receptor is present in keratinocytes. In this in the basal layer. The correlation between the locations paper we show that human epidermal keratinocytes of both mRNA and protein expression in skin indicates that the -opiate receptor has not only been transcribed express a µ-opiate receptor on both the mRNA level and µ but also has a specific function. To prove a function of the protein level. Performing polymerase chain reaction the receptor we performed a functional assay using skin with cDNA libraries from human epidermal keratinocytes organ cultures from human skin transplants. After 48 h gave the polymerase chain reaction products of the incubation with Naloxone or β-endorphin the expression expected length, which were confirmed as µ-opiate recep- of the µ-opiate receptor in epidermis was significantly tors by Southern blot analysis. Using in situ hybridization downregulated compared with the control. These results techniques with a specific probe for µ-opiate receptors show that a functional receptor indeed exists in human we detected the receptor in human epidermis. -
Melanocyte-Stimulating Hormones
The Journal of Neuroscience, August 15, 1996, 16(16):5182–5188 Melanocortin Antagonists Define Two Distinct Pathways of Cardiovascular Control by a- and g-Melanocyte-Stimulating Hormones Si-Jia Li,1 Ka´ roly Varga,1 Phillip Archer,1 Victor J. Hruby,2 Shubh D. Sharma,2 Robert A. Kesterson,3 Roger D. Cone,3 and George Kunos1 1Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia 23298-0613, 2Department of Chemistry, University of Arizona, Tucson, Arizona 85721, and 3Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97210 Melanocortin peptides and at least two subtypes of melano- intracarotid than after intravenous administration. The effects cortin receptors (MC3-R and MC4-R) are present in brain of g-MSH (1.25 nmol) are not inhibited by the intracarotid regions involved in cardiovascular regulation. In urethane- injection of SHU9119 (1.25–12.5 nmol) or the novel MC3-R anesthetized rats, unilateral microinjection of a-melanocyte- antagonist SHU9005 (1.25–12.5 nmol). We conclude that the stimulating hormone (MSH) into the medullary dorsal–vagal hypotension and bradycardia elicited by the release of complex (DVC) causes dose-dependent (125–250 pmol) hy- a-MSH from arcuate neurons is mediated by neural melano- potension and bradycardia, whereas g-MSH is less effective. cortin receptors (MC4-R/MC3-R) located in the DVC, The effects of a-MSH are inhibited by microinjection to the whereas the similar effects of b-endorphin, a peptide derived same site of the novel MC4-R/MC3-R antagonist SHU9119 from the same precursor, are mediated by opiate receptors (2–100 pmol) but not naloxone (270 pmol), whereas the at the same site. -
Insulin Resistance and Impaired Adipogenesis
Review Insulin resistance and impaired adipogenesis Birgit Gustafson, Shahram Hedjazifar, Silvia Gogg, Ann Hammarstedt, and Ulf Smith The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy at the University of Gothenburg, SE-41345 Gothenburg, Sweden The adipose tissue is crucial in regulating insulin sensi- a large waist circumference, markedly enhances both car- tivity and risk for diabetes through its lipid storage diovascular and diabetes risk for a given BMI [5,6]. capacity and thermogenic and endocrine functions. Sub- The molecular abnormalities associated with obesity- cutaneous adipose tissue (SAT) stores excess lipids induced insulin resistance in insulin-responsive tissues through expansion of adipocytes (hypertrophic obesity) and organs (i.e., skeletal muscle, adipose tissue, and the and/or recruitment of new precursor cells (hyperplastic liver) have been investigated extensively and are well obesity). Hypertrophic obesity in humans, a characteris- established. Increased lipids plays an important role and tic of genetic predisposition for diabetes, is associated can promote insulin resistance through the activation of with abdominal obesity, ectopic fat accumulation, and various signaling pathways including protein kinase C the metabolic syndrome (MS), while the ability to recruit (PKC), ceramide, and other lipid molecules and the accu- new adipocytes prevents this. We review the regulation mulation of lipids in target tissues can induce insulin of adipogenesis, its -
Adipose Tissue: Understanding the Heterogeneity of Stem Cells for Regenerative Medicine
biomolecules Review Adipose Tissue: Understanding the Heterogeneity of Stem Cells for Regenerative Medicine Wee Kiat Ong 1,*, Smarajit Chakraborty 2 and Shigeki Sugii 2,3,* 1 School of Pharmacy, Monash University Malaysia, Subang Jaya 47500, Selangor, Malaysia 2 Institute of Bioengineering and Bioimaging (IBB), A*STAR, 31 Biopolis Way, Singapore 138669, Singapore; [email protected] 3 Cardiovascular and Metabolic Disorders Program, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore * Correspondence: [email protected] (W.K.O.); [email protected] (S.S.) Abstract: Adipose-derived stem cells (ASCs) have been increasingly used as a versatile source of mesenchymal stem cells (MSCs) for diverse clinical investigations. However, their applications often become complicated due to heterogeneity arising from various factors. Cellular heterogeneity can occur due to: (i) nomenclature and criteria for definition; (ii) adipose tissue depots (e.g., subcutaneous fat, visceral fat) from which ASCs are isolated; (iii) donor and inter-subject variation (age, body mass index, gender, and disease state); (iv) species difference; and (v) study design (in vivo versus in vitro) and tools used (e.g., antibody isolation and culture conditions). There are also actual differences in resident cell types that exhibit ASC/MSC characteristics. Multilineage-differentiating stress-enduring (Muse) cells and dedifferentiated fat (DFAT) cells have been reported as an alternative or derivative source of ASCs for application in regenerative medicine. In this review, we discuss these factors that contribute to the heterogeneity of human ASCs in detail, and what should be taken into consideration Citation: Ong, W.K.; Chakraborty, S.; for overcoming challenges associated with such heterogeneity in the clinical use of ASCs.